Overview

Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye

Status:
Withdrawn
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to specifically assess the effect of intravitreal aflibercept injections on the health of cells and the flow of blood through the retinal blood vessels by using advanced technology called adaptive optics.
Phase:
Phase 4
Details
Lead Sponsor:
University of Rochester
Treatments:
Aflibercept